Reyners AKL - Search Results

1

Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.

Eerkens AL, Brummel K, Vledder A, Paijens ST, Requesens M, Loiero D, van Rooij N, Plat A, Haan FJ, Klok P, Yigit R, Roelofsen T, de Lange NM, Klomp R, Church D, Ter Elst A, Wardenaar R, Spierings D, Foijer F, Koelzer VH, Bosse T, Bart J, Jalving M, Reyners AKL, de Bruyn M, Nijman HW. Eerkens AL, et al. Among authors: reyners akl. Nat Commun. 2024 Sep 3;15(1):7695. doi: 10.1038/s41467-024-52098-8. Nat Commun. 2024. PMID: 39227583 Free PMC article. Clinical Trial.

2

Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitors.

Hooiveld-Noeken JS, Eggen AC, Rácz E, de Vries EGE, Reyners AKL, Jalving M. Hooiveld-Noeken JS, et al. Among authors: reyners akl. Crit Rev Oncol Hematol. 2022 Dec;180:103855. doi: 10.1016/j.critrevonc.2022.103855. Epub 2022 Oct 17. Crit Rev Oncol Hematol. 2022. PMID: 36257534 Free article. Review.

3

End-of-life care for patients with advanced ovarian cancer in the Netherlands: A retrospective registry-based analysis.

Broekman KE, van der Aa MA, Nijman HW, Jalving M, Reyners AKL. Broekman KE, et al. Among authors: reyners akl. Gynecol Oncol. 2022 Jul;166(1):148-153. doi: 10.1016/j.ygyno.2022.04.017. Epub 2022 May 26. Gynecol Oncol. 2022. PMID: 35644730 Free article.

4

Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study.

Vermeij R, Leffers N, Hoogeboom BN, Hamming IL, Wolf R, Reyners AK, Molmans BH, Hollema H, Bart J, Drijfhout JW, Oostendorp J, van der Zee AG, Melief CJ, van der Burg SH, Daemen T, Nijman HW. Vermeij R, et al. Int J Cancer. 2012 Sep 1;131(5):E670-80. doi: 10.1002/ijc.27388. Epub 2012 Jan 31. Int J Cancer. 2012. PMID: 22139992 Clinical Trial.

5

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases.

Eggen AC, Hospers GAP, Bosma I, Kramer MCA, Reyners AKL, Jalving M. Eggen AC, et al. Among authors: reyners akl. BMC Cancer. 2022 Mar 5;22(1):247. doi: 10.1186/s12885-022-09316-7. BMC Cancer. 2022. PMID: 35247992 Free PMC article.

6

Diagnosis and Treatment Monitoring of a Patient with Gastrointestinal Stromal Tumor by Next-Generation Sequencing and Droplet Digital Polymerase Chain Reaction Assay of a PDGFRA Mutation in Plasma-Derived Cell-Free Tumor DNA.

Boonstra PA, Ter Elst A, Tibbesma M, Gietema JA, Schuuring E, Reyners AKL. Boonstra PA, et al. Among authors: reyners akl. Oncologist. 2019 Jun;24(6):e387-e390. doi: 10.1634/theoncologist.2018-0460. Epub 2019 Jan 22. Oncologist. 2019. PMID: 30670599 Free PMC article.

7

Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.

de Jong RA, Nijman HW, Wijbrandi TF, Reyners AK, Boezen HM, Hollema H. de Jong RA, et al. Mod Pathol. 2011 Oct;24(10):1368-79. doi: 10.1038/modpathol.2011.88. Epub 2011 May 13. Mod Pathol. 2011. PMID: 21572397 Free article.

8

Metformin: taking away the candy for cancer?

Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, Gans RO, de Vries EG. Jalving M, et al. Eur J Cancer. 2010 Sep;46(13):2369-80. doi: 10.1016/j.ejca.2010.06.012. Epub 2010 Jul 23. Eur J Cancer. 2010. PMID: 20656475 Review.

9

Levels of circulating tumor DNA correlate with tumor volume in gastro-intestinal stromal tumors: an exploratory long-term follow-up study.

Bleckman RF, Haag CMSC, Rifaela N, Beukema G, Mathijssen RHJ, Steeghs N, Gelderblom H, Desar IME, Cleven A, Ter Elst A, Schuuring E, Reyners AKL. Bleckman RF, et al. Among authors: reyners akl. Mol Oncol. 2024 May 24. doi: 10.1002/1878-0261.13644. Online ahead of print. Mol Oncol. 2024. PMID: 38790141 Free article.

10

Radical surgery in patients with residual disease after (chemo)radiation for cervical cancer.

Boers A, Arts HJ, Klip H, Nijhuis ER, Pras E, Hollema H, Wisman GB, Nijman HW, Mourits MJ, Reyners AK, de Bock GH, Thomas G, van der Zee AG. Boers A, et al. Int J Gynecol Cancer. 2014 Sep;24(7):1276-85. doi: 10.1097/IGC.0000000000000171. Int J Gynecol Cancer. 2014. PMID: 24987914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page